Tuesday, 29 May 2012
With an annual healthcare expenditure expected to be of USD 305 million by 2015, and 6,801 hospitals and 371,000 medical doctors, representing 4.05% of the world’s total Brazil is simply a market too big to ignore.
Scientist looking into a microscope
Life Sciences sector in Brazil
Brazil has the largest healthcare and medical devices market in Latin America. Healthcare is mainly provided by the state, but private partners in this sector have quickly increased their investments over the last eight years.
Market overview
With an annual healthcare expenditure expected to be of USD 305 million by 2015, and 6,801 hospitals and 371,000 medical doctors, representing 4.05% of the world’s total Brazil is simply a market too big to ignore.
Brazil is growing rapidly and is expected to become the world’s 5th largest economy by 2030. In line with this growth, the healthcare market in the country is expected to grow at a compound annual growth rate of 35% for the next ten years (compared to the global average rate of 4.1%), driven by increasing opportunities in the sector. By 2015 the value of the market is estimated to be approximately £85 billion.
The key drivers for this growth forecast are the higher purchasing power of the low and middle classes, the higher life expectancy of the general population, the higher population, and the growth in the home care market. FIFA 2014 World Cup and the Olympic Games in 2016 will also drive government investments to the healthcare sector, starting in 2012.
The pharmaceutical industry corresponds to 2% of the global sales market and is the 10th amongst world leaders in the sector. The Brazilian pharmaceutical industry is comprised of 553 companies, more than 50,000 pharmacies and more than 500 distributors of pharmaceutical products - the largest market in LA in 2008 with £7Bi sales (39.6% share of the Latin American market).
Key opportunities
High end medical devices: mostly all of the low-tech medical technology is produced domestically, but for high-end and novel technologies the consumer market has to look overseas.
E-health and remote diagnostics: The Brazilian public health system, along with the private sector, is investing in remote access for a large share of the population through e-health technology, which will expand the universal coverage to more people.
Medical education and training: The economic growth the country expects will have an impact on its education sector. Many Brazilian institutions such as universities and others are keen to sign deals with foreign universities and the market is huge for the various prestigious UK degrees, especially for the MDN education where partnerships were not yet made.
Latest export opportunities – Life Sciences
Latest export opportunities – Brazil
Getting into the market
The Brazilian government establishes specific regulations for the registration, licensing and/or exemption of Life Sciences products. The National Health Surveillance Agency – ANVISA – was established in 1999 to improve the health protection of the population by exercising sanitary control over the production and commercialisation of products and services subject to sanitary surveillance. The role of ANVISA is equivalent to the role of the MHRA in the UK. In order to export and distribute products in Brazil, foreign companies must either establish a local manufacturing unit, a local office or appoint a Brazilian partner to hold the registration with ANVISA.
The selection of the right partner is essential for the success of your company in Brazil. A Brazilian person or company must have a Company Working Allowance certificate, issued by ANVISA, to become your Brazilian Registration Holder (BRH). It is common for distributors to be the BRH, but there are also registration holding companies and consultants specialised in holding ANVISA licences. This permit allows your local partner to import, distribute, store and sell the product in Brazil. This point of contact in Brazil will be considered as the legal representative of the exporting company in the country.
More about doing business in Brazil
Contacts
Market intelligence is critical when doing business overseas, and UKTI can provide bespoke market research and support during overseas visits though our chargeable Overseas Market Introduction Service (OMIS).
To commission research or for general advice about the market, get in touch with our specialists in country - or contact your local international trade team.
Carolina Costa, British Consulate-General São Paulo. Tel: +55 11 3094-2745 or email: carolina.costa@fco.gov.uk.
Daniel Meninelli, British Consulate-General São Paulo. Tel: +55 11 3094-1881 or email: daniel.meninelli@fco.gov.uk.
Contact your local international trade team
Events
UKTI runs a range of events for exporters, including seminars in the UK, trade missions to overseas markets and support for attendance at overseas trade shows.
CPhI South America
21-23 August 2012
BioPartnering Latin America
11-13 September 2012
Analitica Latin America
24-26 September 2013
http://www.analiticanet.com.br/en/
Reatech
18-21 April 2013
Hospitalar Tradeshow
22-25 May 2012
http://www.hospitalar.com.br
FCE Pharma
29-31 May 2012
-
Share this
- Delicious
- Digg
- reddit
- StumbleUpon
- Facebook
- Twitter
- LinkedIn
Email this Print this